Suppr超能文献

免疫显性与免疫主导:开发有效的基于CD8 + T细胞的癌症疫苗的关键因素。

Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.

作者信息

Chen Weisan, McCluskey James

机构信息

T Cell Laboratory, Ludwig Institute for Cancer Research, Austin Health, Heidelberg, VIC 3084, Australia.

出版信息

Adv Cancer Res. 2006;95:203-47. doi: 10.1016/S0065-230X(06)95006-4.

Abstract

The focusing of cellular immunity toward one, or just a few, antigenic determinant, even during immune responses to complex microorganisms or antigens, is known as immunodominance. Although described in many systems, the mechanisms of determinant immunodominance are only just beginning to be appreciated, especially in relation to the interplay between T cells of differing specificities and the interactions between T cells and the antigen-presenting cells (APCs). The outcome of these cellular interactions can lead to a form of immune suppression of one specificity by another-described as "immunodomination". The specific and detailed mechanisms involved in this process are now partly defined. A full understanding of all the factors that control immunodominance and influence immunodomination will help us to develop better viral and cancer vaccines.

摘要

即使在针对复杂微生物或抗原的免疫反应过程中,细胞免疫针对一种或仅几种抗原决定簇的聚焦现象,被称为免疫显性。尽管在许多系统中都有描述,但决定簇免疫显性的机制才刚刚开始被认识,特别是在不同特异性T细胞之间的相互作用以及T细胞与抗原呈递细胞(APC)之间的相互作用方面。这些细胞间相互作用的结果可能导致一种特异性对另一种特异性的免疫抑制形式——被描述为“免疫主导”。现在已经部分确定了这个过程中涉及的具体和详细机制。全面了解控制免疫显性和影响免疫主导的所有因素,将有助于我们开发出更好的病毒疫苗和癌症疫苗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验